The 2026 World Health Organization dementia guideline says diabetes care may be offered to adults with diabetes to reduce cognitive decline or dementia. For adults over 65, high costs, complex prescriptions, and memory-related health issues often get in the way.
Cognitive decline means a gradual loss of memory, thinking speed, and planning ability that can precede dementia. Up to 45% of dementia risk could be prevented or delayed by acting on changeable factors including diabetes, according to the WHO news release. Older adults carry the largest share of diabetes, so these access barriers matter directly for brain health.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Check eligibility on NIH’s official study page — Use this page to check the study’s participation requirements.
- Explore the official data from CDC — Use this primary source to review the underlying data.
Table of Contents
- What did WHO recommend on diabetes?
- Why does diabetes matter more after 65?
- Why do doses get skipped?
- What makes treatment easier to follow?
What did WHO recommend on diabetes?
The guideline makes a conditional recommendation with very low certainty, as described in the Guideline Central summary. It says diabetes management may be offered specifically to lower cognitive decline or dementia risk. That wording means it is an option to discuss, not a firm rule for every patient.
The full WHO publication, listed in the WHO publications catalogue, is Risk reduction of cognitive decline and dementia: WHO guidelines, second edition. It expands the 2019 guidance to cover behaviours, cardiometabolic conditions, hearing loss, air pollution, and multidomain interventions. Diabetes is one cardiometabolic piece inside that wider prevention plan.
Why does diabetes matter more after 65?
Diabetes affects 28.8% of U.S. adults aged 65 or older, based on August 2021–August 2023 NHANES data, according to the CDC National Diabetes Statistics Report. That makes older adults the highest-prevalence age group. More people at risk means more people facing daily treatment demands.
The brain risk is also higher. Curtin University researchers in Alzheimer's Research & Therapy found about 53% higher adjusted relative risk of Alzheimer's disease in people with type 2 diabetes. Incidence was 4.7 per 1,000 person-years across 40 studies. For a caregiver, that link makes steady diabetes care part of brain care.
Why do doses get skipped?
Cost blocks access. Among insulin users aged 65 or older, 11.2% rationed insulin in the prior year by skipping doses, taking less, or delaying purchase, in a 2021 CDC NHIS analysis reported by Harvard and Hunter College via the MedicalXpress report. Rationing lowers blood-sugar control and raises fall and confusion risk. Anyone cutting doses to save money needs prompt help, not shame.
Daily management can also break down for health reasons. The American Diabetes Association 2025 older-adult standards direct annual screening for cognitive impairment, depression, falls, frailty, hypoglycemia, and polypharmacy. Those conditions impair diabetes self-management and quality of life. Memory loss causes missed doses, depression drains follow-through, and low blood sugar causes shakiness, sweating, and falls.
What makes treatment easier to follow?
Simpler routines help. For older adults, the American Diabetes Association advises simplifying complex and insulin regimens and preferring drugs with low hypoglycemia risk.
The 2023 AGS Beers Criteria advise avoiding all sulfonylureas as first- or second-line therapy because of hypoglycemia and cardiovascular risk. Fewer pills, steady timing, and low-risk drugs reduce mistakes. A reader or caregiver can make the next visit more useful: Bring all pill bottles to the visit so the clinician can spot duplicates and hypoglycemia risks.
- List every drug, dose, cost problem, and missed-dose pattern.
- Ask whether the regimen can be simplified with lower hypoglycemia risk.
- Ask about annual checks for memory, mood, falls, frailty, and drug burden.
You Might Also Like
- Hearing Aids in the 2026 WHO Dementia Guideline: What Is Established and What Is Still Being Studied for Adults Over 65
- Blood Pressure in the 2026 WHO Dementia Guideline: What Is Established and What Is Still Being Studied for Adults Over 65
- Air Pollution in the 2026 WHO Dementia Guideline: What Is Established and What Is Still Being Studied for Adults Over 65





